Heart Disease Clinical Trials in Phoenix

Showing 61-80 of 196 trials

A Study of Mavacamten in Participants With HFpEF and Elevation of NT-proBNP With or Without Elevation of cTnT

NCT04766892

This is a Phase 2a proof-of-concept study to assess safety, tolerability, and preliminary efficacy of mavacamten treatment on biomarker levels in participants with heart failure with preserved ejection fraction (HFpEF) and elevation of NT-proBNP with or without elevation of cTnT. Data from this study will inform future study designs of mavacamten in patients with HFpEF.

Heart Failure With Preserved Ejection Fraction

Bristol-Myers Squibb30 participantsStarted Mar 2021

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Tucson, Arizona, United States +18 more locations

ACTIVE_NOT_RECRUITINGPHASE3< 1 mile

Cardiovascular Outcome Study to Evaluate the Effect of Obicetrapib in Patients With Cardiovascular Disease

NCT05202509

This study will be a placebo-controlled, double-blind, randomized, phase 3 study in participants with Atherosclerotic Cardiovascular Disease (ASCVD) who are not adequately controlled despite maximally tolerated lipid-lowering therapy.

Atherosclerotic Cardiovascular Disease

NewAmsterdam Pharma9,541 participantsStarted Feb 2022

Alexander City, Alabama, United States • Birmingham, Alabama, United States • Birmingham, Alabama, United States +588 more locations

A Study of Mavacamten in Participants With HFpEF and Elevation of NT-proBNP With or Without Elevation of cTnT

Cardiovascular Outcome Study to Evaluate the Effect of Obicetrapib in Patients With Cardiovascular Disease

Heart Disease Trials in Other Cities

The Impact of a Parenting Intervention on Latino Youth Health Behaviors

Genetic Risk Stratification for Primary Prevention of CAD in Men and Pre & Post-menopausal Women

FUnctional diagnoSIs of corONary Stenosis (FUSION)

Multicenter Automatic Defibrillator Implantation Trial With Subcutaneous Implantable Cardioverter Defibrillator

ILUMIEN IV: OPTIMAL Percutaneous Coronary Intervention (PCI)

Distal Evaluation of Functional Performance with Intravascular Sensors to Assess the Narrowing Effect: Guided Physiologic Stenting

REmodeling the Left Ventricle With Atrial Modulated Pacing

Benefits of µCor in Ambulatory Decompensated Heart Failure

Benefits of Microcor in Ambulatory Decompensated Heart Failure

Caffeine's Effect on Regadenoson Administration With Single Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)

Advancing Understanding of Transportation Options

Clinical Study Assessing the Efficacy and Safety of Macitentan in Fontan-palliated Subjects

Utility of Donor-Derived Cell Free DNA in Association With Gene Expression Profiling

ELUCIDATE FFRct Study

Early Feasibility Evaluation of the AccuCinch® Ventricular Restoration System in Patients With Heart Failure and Reduced Ejection Fraction

The CorCinch - Functional Mitral Valve Regurgitation (FMR) Study

Congenital Heart Disease: Impact on Learning and Development in Down Syndrome (CHILD-DS)

Communication During Hospitalization About Resuscitation Trial

Other Conditions in Phoenix